Verified Nov 2026
Electronics & Software
·
Miami, Florida
·
Since 2018
Heru is a medical technology company founded in 2018 and headquartered in Miami, Florida, with an estimated 200-500 employees and an estimated revenue band of $10-50M. It originated as a spinoff from the University of Miami's Bascom Palmer Eye Institute and develops AI-powered vision diagnostics and augmentation software for augmented and virtual reality devices, along with a wearable diagnostic device and a cloud-based results platform. The company serves healthcare professionals and facilities in the eye care, ophthalmology, and optometry sectors. In September 2026, it announced the launch of PretestPro for its Heru Prime VR-powered diagnostic headset.
Heru at a glance
Revenue
$10-50M
Est. band
Employees
200-500
Founded
2018
Headquarters
Miami, Florida
Import activity
264
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
264
Named foreign suppliers
38
Top origins
China · Malaysia · Vietnam · South Korea
Shared foreign counterparties do not establish that these companies buy from Heru.
What this tells a buyer
Heru announced the launch of PretestPro for its Heru Prime VR-powered diagnostic headset in September 2026, following an earlier showcase of the product at Vision Expo in March 2026.
Heru's offerings include patented AI-powered vision diagnostics software, a wearable medical diagnostic device, and a cloud-based platform that generates test results, and the company reports having tested more than 1 million eyes as of October 2025.
Heru is privately held, and its estimated revenue band of $10-50M is an estimate rather than a reported figure.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
Overview
Heru is a medical technology company founded in 2018 and headquartered in Miami, Florida, with an estimated 200-500 employees and an estimated revenue band of $10-50M. It originated as a spinoff from the University of Miami's Bascom Palmer Eye Institute and develops AI-powered vision diagnostics and augmentation software for augmented and virtual reality devices, along with a wearable diagnostic device and a cloud-based results platform. The company serves healthcare professionals and facilities in the eye care, ophthalmology, and optometry sectors. In September 2026, it announced the launch of PretestPro for its Heru Prime VR-powered diagnostic headset.
At a glance
Attribute | Detail |
|---|---|
Founded | 2018 |
Headquarters | Miami, Florida |
Employees | 200-500 |
Revenue | $10-50M (estimated) |
Primary capability | Electronics & Software |
What Heru makes
Heru's offerings include patented AI-powered vision diagnostics software, a wearable medical diagnostic device, and a cloud-based platform that generates test results, and the company reports having tested more than 1 million eyes as of October 2025.
Products and capabilities described on the company's own site include LED (source: seeheru.com).
Trade and customs footprint
Heru announced the launch of PretestPro for its Heru Prime VR-powered diagnostic headset in September 2026, following an earlier showcase of the product at Vision Expo in March 2026. US customs bill-of-lading records list 264 inbound shipments across 38 foreign suppliers, with top origins including China · Malaysia · Vietnam · South Korea.
Latest developments
2026-10-01 — Heru brought wearable vision diagnostics onto campus at Miami Country Day School, alongside American Vision Group. Students and faculty got to try a faster, more modern way to check their vision, and … | Heru (linkedin.com)
2026-09-16 — Heru launches PretestPro for streamlined eye exam pretesting (healio.com)
2026-09-08 — Heru Announces the Launch of PretestPro™ for the Heru Prime VR-Powered Diagnostic Headset | Heru (seeheru.com)
2026-03-12 — Heru Showcases PretestPro™ for the Heru VR-Powered Diagnostic Headset at Vision Expo | Heru (seeheru.com)
2025-10-16 — Heru Surpasses 1 Million Eyes Tested, Cementing Leadership in AI-Powered Vision Diagnostics | Heru (seeheru.com)
2025-06-26 — 🌟 Exciting News! 🌟 I am thrilled to announce that I have taken on a new role with Heru, a leader in AI diagnostics known for its highest sensitivity in vision care. | David F. (linkedin.com)
Company details
Heru is privately held, and its estimated revenue band of $10-50M is an estimate rather than a reported figure. Heru was founded in 2018, has an estimated 200-500 employees, and is headquartered in Miami, Florida.
Frequently asked questions
What does Heru make?
Heru is a medical technology company founded in 2018 and headquartered in Miami, Florida, with an estimated 200-500 employees and an estimated revenue band of $10-50M. It originated as a spinoff from the University of Miami's Bascom Palmer Eye Institute and develops AI-powered vision diagnostics and augmentation software for augmented and virtual reality devices, along with a wearable diagnostic device and a cloud-based results platform. The company serves healthcare professionals and facilities in the eye care, ophthalmology, and optometry sectors. In September 2026, it announced the launch of PretestPro for its Heru Prime VR-powered diagnostic headset.
Where is Heru headquartered?
Heru is headquartered in Miami, Florida (201 S Biscayne Blvd, Miami, Florida, 33131-2301).
When was Heru founded?
Heru was founded in 2018.
How big is Heru?
Heru has an estimated 200-500 employees, with revenue in the $10-50M range (estimated).
Does Heru import from overseas suppliers?
US customs bill-of-lading records show 264 inbound shipments for Heru, with top origins including China · Malaysia · Vietnam · South Korea.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.